000 01338 a2200361 4500
005 20250517142737.0
264 0 _c20171229
008 201712s 0 0 eng d
022 _a1473-4877
024 7 _a10.1080/03007995.2017.1301903
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAkerley, Wallace L
245 0 0 _aImpact of a multivariate serum-based proteomic test on physician treatment recommendations for advanced non-small-cell lung cancer.
_h[electronic resource]
260 _bCurrent medical research and opinion
_c06 2017
300 _a1091-1097 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMutation
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aProteomics
700 1 _aArnaud, Alix M
700 1 _aReddy, Bibas
700 1 _aPage, Ray D
773 0 _tCurrent medical research and opinion
_gvol. 33
_gno. 6
_gp. 1091-1097
856 4 0 _uhttps://doi.org/10.1080/03007995.2017.1301903
_zAvailable from publisher's website
999 _c26953337
_d26953337